Chrystal Capital introduces FO and UHNWI co-investors into the $175m Series C financing of The Every Company (formally Clara Foods), alongside Rage Capital
Chrystal Capital Partners LLP (“Chrystal”), a Mayfair-based corporate finance and investment house, is pleased to announce that it has brought co-investors from its family office and UHNWI network into The EVERY Company, a leading precision fermentation platform accelerating a global transition to animal-free protein. The round was co-led by new investor, McWin, and existing investor, Rage Capital. Other new and existing investors joined the round including Temasek, Grosvenor’s Wheatsheaf Group, and TO Ventures.
“Giving family offices access to high growth companies backed by blue chip investors is what Chrystal Capital prides itself on. Rage Capital is an excellent partner with its vast experience and success in the food tech investing space. We will be bringing additional deals from them to our network in Q1 and I would encourage any investors interested in the space to reach out.”
About The Every Company
The EVERY Company, headquartered in South San Francisco, is a market leader in engineering, manufacturing and formulating animal-free, animal proteins as ingredients for the global food and beverage industry. Originally founded as Clara Foods in 2014, EVERY™ rebranded in 2021 to better capture its vision to bring animal-free proteins to everyone, everywhere. The company use sugar, yeast, and advanced yeast engineering and fermentation technologies to selectively cultivate yeast for the production of proteins, thereby enabling customers to get healthy, sustainable, and affordable protein items.
Founded by Arturo Elizondo in 2014, Clara’s mission is to create a better, cheaper alternative to animal proteins in both B2C and B2B applications – starting with the egg’s $200B addressable market. Today, the company has developed a comprehensive platform from protein discovery to industry-leading yeast productivity, enabling Every to identify both novel proteins or novel applications of known proteins and synthesize those in mass quantities.
For more information, see www.theeverycompany.com.
About Rage Capital
Rage Capital is a specialist venture capital firm based in New York, investing in cutting edge technology to change the way we eat, live and interact with our planet. Other investments in its portfolio include Blue Nalu, Motif, Ripple, Reef, Future Farm and Splendid Spoon.
For more information, see www.rage-capital.com.
For further information please contact:
James Innes
Managing Partner
james.innes@chrystalcapital.com
https://www.chrystalcapital.com